Search

everythinglearnresearchcommunity

for

Search:↓

Over 45% of patients with alopecia areata benefit from ritlecitinib, mostly within a year.

Low testosterone and 5α-reductase inhibitors can harm men's metabolic and sexual health; testosterone therapy may help, but discussing 5α-RIs' side effects is important.

Dabrafenib was effective and well tolerated in treating thyroid cancer with a specific mutation.

Congenital triangular alopecia is more common than thought and some treatments can be beneficial for appearance concerns.

The combination treatment showed a higher response rate but no significant survival benefits.

HOTTIP and miR-10b contribute to glioma therapy resistance by affecting cell behavior, suggesting they could be targets for treatment.

Targeted cancer drugs can cause skin reactions, so dermatologists must manage these effects.

Baricitinib may effectively treat both alopecia areata and immune thrombocytopenia.

Taking 5-alpha reductase inhibitors does not increase the risk of breast cancer in men.

A man's severe skin reaction from cancer treatment improved with early diagnosis and proper medication.

Using PDRN injections and RF treatments improved revision nose surgery results without major side effects.

Combining hair transplantation with PRP is more effective for treating hair loss than hair transplantation alone.

5-alpha-reductase inhibitors help treat urinary symptoms from an enlarged prostate.

Systematic end-of-trial biopsies are the most reliable way to assess outcomes.

Trichoscopy effectively diagnoses temporal triangular alopecia in children.

Baricitinib was effective in treating hair loss in adults with alopecia areata according to patient feedback.

Fragile hair in children is rarely linked to trichothiodystrophy (TTD).

BIMA grafting can be safely done in females with careful preparation.

A woman developed male characteristics after using unregulated hormone therapy.

The study concludes that Traction Alopecia is often overlooked in women and children of color, and better recognition and follow-up care are needed.

A multidisciplinary approach is crucial for managing Silver-Russell syndrome effectively.

Baricitinib improved platelet counts and alopecia in a 16-year-old with chronic immune thrombocytopenia.

Ritlecitinib reduces alopecia areata symptoms by blocking JAK3/TEC signaling and T-cell activity.

TLR4 is important in aging-related diseases and could be a new treatment target.

A young boy with a rare skin and nail condition improved significantly with simple topical treatments.

A bladder rupture from prostate treatment was healed with catheterization and antibiotics.

A new topical treatment may prevent hair loss from cancer therapy by adjusting cell death processes in hair follicles.

Early diagnosis, genetic testing, and personalized care are essential for managing tuberous sclerosis.

Trichoscopy effectively diagnoses temporal triangular alopecia in children.

Robertsonian translocation can cause recurrent miscarriages.